Open AccessComparison of ascending doses of olmesartan medoxomil (O), losartan potassium (L) and valsartan (V) in patients (PTS) with essential hypertension (HTN)
Author(s) -
Thomas D. Giles,
S Oparil,
T SILFANI,
F WALKER
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.163
Subject(s) - medicine , losartan , placebo , valsartan , clinical endpoint , losartan potassium , olmesartan , urology , blood pressure , dosing , randomized controlled trial , angiotensin ii , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom